• Submitted by: admin
• Health and Medicine
• 03 / 23 / 2007

According to the agreement, Cuban company Heber Biotec S.A. will supply Hapharco Co., underway in Hanoi, vaccines against hepatitis B and Haemophilus lnfluenzae Type B.

The value of those accords comes to $2.2 million, double the figure compared to 2006.

"This is the largest volume reached so far," Mai Thao told Prensa Latina, who inked transactions as Heber Biotec S.A. representative for Asia.

These contracts were signed by Bui Thanh Son, general director of Vietnamses Hapharco Co., producer of vaccines and other bio-medicines.

Cuban ambassador Jesus Aise, who presided over the ceremony, expressed that this step reflects the two country's desire to broaden trade links, and the biotechnology sector is one of those that contribute most with that purpose.

"The aim is not only to satisfy the demand in the Vietnamese market, but also to export to third regional countries, in which there is a great demand for those medications," said Son.

Source: Prensa Latina